$4.2B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | ABIVAX SA Abivax Sa | 6.0M | −7.3% | $801M | 19.2% |
| 2 | TNGX Tango Therapeutics Inc | 9.1M | −13.8% | $284M | 6.8% |
| 3 | CGON Cg Oncology Inc | 3.7M | +0.0% | $261M | 6.3% |
| 4 | COGT Cogent Biosciences Inc | 4.9M | −1.9% | $188M | 4.5% |
| 5 | IMVT Immunovant Inc | 4.5M | +0.0% | $172M | 4.1% |
| 6 | SYRE Spyre Therapeutics Inc | 1.9M | +0.0% | $169M | 4.1% |
| 7 | DNTH Dianthus Therapeutics Inc | 1.7M | +0.0% | $163M | 3.9% |
| 8 | MIRM Mirum Pharmaceuticals Inc | 1.1M | +0.0% | $124M | 3.0% |
| 9 | ZLAB Zai Lab Ltd | 6.1M | — | $117M | 2.8% |
| 10 | AMLX Amylyx Pharmaceuticals Inc | 6.2M | +0.0% | $112M | 2.7% |
| 11 | GLUE Monte Rosa Therapeutics Inc | 4.6M | +0.0% | $112M | 2.7% |
| 12 | BCRX Biocryst Pharmaceuticals Inc | 11.0M | +0.0% | $110M | 2.6% |
| 13 | VOR Vor Biopharma Inc | 5.7M | +0.0% | $104M | 2.5% |
| 14 | TYRA Tyra Biosciences Inc | 3.2M | +0.0% | $104M | 2.5% |
| 15 | DYN Dyne Therapeutics Inc | 4.6M | +0.0% | $103M | 2.5% |
| 16 | IRON Disc Medicine Inc | 1.3M | +0.0% | $98M | 2.4% |
| 17 | RLAY Relay Therapeutics Inc | 4.3M | +0.0% | $80M | 1.9% |
| 18 | SVRA Savara Inc | 12.4M | +0.0% | $76M | 1.8% |
| 19 | AURA Aura Biosciences Inc | 9.5M | — | $68M | 1.6% |
| 20 | RVMD Revolution Medicines Inc | 340,899 | −40.9% | $64M | 1.5% |
| 21 | TRAX First Tracks Biotherapeutics | 2.9M | — | $58M | 1.4% |
| 22 | KOD Kodiak Sciences Inc | 1.4M | +0.0% | $56M | 1.4% |
| 23 | AVTX Avalo Therapeutics Inc | 3.0M | +308.6% | $56M | 1.3% |
| 24 | LBRX Lb Pharmaceuticals Inc | 1.4M | −21.3% | $47M | 1.1% |
| 25 | IPSC Century Therapeutics Inc | 17.8M | +0.0% | $43M | 1.0% |
| 26 | TECX Tectonic Therapeutic Inc | 1.2M | +0.0% | $41M | 1.0% |
| 27 | XNCR Xencor Inc | 2.5M | +0.0% | $39M | 0.9% |
| 28 | SRZN Surrozen Inc | 1.5M | +0.0% | $38M | 0.9% |
| 29 | EDIT Editas Medicine Inc | 11.1M | — | $36M | 0.9% |
| 30 | MBX Mbx Biosciences Inc | 650,000 | +0.0% | $36M | 0.9% |
| 31 | PHVS Pharvaris N V | 1.0M | — | $35M | 0.8% |
| 32 | SLN Silence Therapeutics Plc | 3.0M | +0.0% | $33M | 0.8% |
| 33 | INFLARX NV Inflarx Nv | 14.5M | — | $32M | 0.8% |
| 34 | ALT Altimmune Inc | 10.0M | — | $30M | 0.7% |
| 35 | JANX Janux Therapeutics Inc | 1.8M | +0.0% | $27M | 0.7% |
| 36 | CATX Perspective Therapeutics Inc | 7.9M | +0.0% | $27M | 0.6% |
| 37 | AGMB Agomab Therapeutics Nv | 2.1M | +0.0% | $27M | 0.6% |
| 38 | BHVN Biohaven Ltd | 1.8M | −61.6% | $26M | 0.6% |
| 39 | AKTS Aktis Oncology Inc | 696,560 | — | $22M | 0.5% |
| 40 | ALEC Alector Inc | 10.0M | +0.0% | $20M | 0.5% |
| 41 | FORTE BIOSCIENCES INC Forte Biosciences Inc | 920,000 | — | $20M | 0.5% |
| 42 | MNPR Monopar Therapeutics Inc | 203,327 | +53.9% | $19M | 0.5% |
| 43 | OCUL Ocular Therapeutix Inc | 1.6M | +0.0% | $16M | 0.4% |
| 44 | ADCT Adc Therapeutics Sa | 11.4M | +0.0% | $12M | 0.3% |
| 45 | ALXO Alx Oncology Hldgs Inc | 5.7M | −56.5% | $12M | 0.3% |
| 46 | TRDA Entrada Therapeutics Inc | 1.1M | −53.7% | $8M | 0.2% |
| 47 | CGEM Cullinan Therapeutics Inc | 406,786 | +0.0% | $7M | 0.2% |
| 48 | ARVN Arvinas Inc | 707,098 | −70.4% | $6M | 0.1% |
| 49 | KRRO Korro Bio Inc | 416,301 | +0.0% | $5M | 0.1% |
| 50 | RACC Research Alliance Corp Iii | 500,000 | — | $5M | 0.1% |